| Investor Type | Firm |
| Investing | United States |
| Investment Range | $72,300,000 - $72,300,000 |
Invemed Associates is an investment banking firm based in New York, New York. They specialize in providing financial services to health-care and high-technology companies. Their investment focus aligns with sectors that exhibit strong growth potential and innovation, such as biotechnology, medical devices, pharmaceuticals, and cutting-edge technology firms.
Invemed Associates offers a range of services, including advisory for mergers and acquisitions, facilitating public offerings, and arranging private placements. They leverage their expertise, industry knowledge, and networks to support companies in these sectors to achieve their strategic financial objectives.
The firm stands out for its commitment to nurturing long-term relationships with their clients, ensuring they provide tailored financial solutions to meet the unique needs of each company. Invemed Associates is known for their rigorous due diligence process and their ability to execute complex transactions with skill and precision.
With their established investment minimum and maximum both set at $72,300,000, they position themselves as a fund that engages in significant investments, indicating a strategy that targets substantial stakes in companies with high growth and innovation potential. Their high entry point for investments suggests that they work with well-established entities or high-value startups within the specialized fields they focus on.
The firm appears to emphasize a strategic approach to investing, where their financial support is complemented by the provision of in-depth industry insights and a hands-on engagement model to drive value creation in their portfolio companies.


